NT-proBNP Rapid Quantitative Test - India CDSCO Medical Device Registration

NT-proBNP Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_26df5373963fc4966ac53abb051c4677_bf7c4c88174a0650b17b3c09a2c22fac. This device is marketed under the brand name Cardiac Troponin T. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

NT-proBNP Rapid Quantitative Test

UID: IMP/IVD/2022/000074_26df5373963fc4966ac53abb051c4677_bf7c4c88174a0650b17b3c09a2c22fac

Brand Name

Cardiac Troponin T

License Holder

FINOVA HEALTHCARE PRIVATE LIMITED

Device Class

Class C

Approving Authority

CDSCO

Product Information

The Aehealth NT-proBNP Rapid Test along with Aehealth Fluorescence Immunoassay Analyzer (Cardiac Troponin T) is a fluorescence immunoassay for quantitative measurement of N-terminal prohormone of brain natriuretic peptide (Cardiac Troponin T) in human whole blood, serum or plasma